Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) EVP Patrick Burnett sold 943 shares of the stock in a transaction dated Monday, November 2nd. The stock was sold at an average price of $31.86, for a total transaction of $30,043.98. Following the completion of the sale, the executive vice president directly owned 116,649 shares in the company, valued at approximately $3,716,437.14. The trade was a 0.80% decrease in their ownership of…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.